BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 12866026)

  • 1. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
    Mercapide J; Lopez De Cicco R; Castresana JS; Klein-Szanto AJ
    Int J Cancer; 2003 Sep; 106(5):676-82. PubMed ID: 12866026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
    Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
    Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
    J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness.
    Mercapide J; Lopez De Cicco R; Bassi DE; Castresana JS; Thomas G; Klein-Szanto AJP
    Clin Cancer Res; 2002 Jun; 8(6):1740-6. PubMed ID: 12060611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma.
    Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN
    J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.
    Rossi M; Rooprai HK; Maidment SL; Rucklidge GJ; Pilkington GJ
    Anticancer Res; 1996; 16(1):121-8. PubMed ID: 8615596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y
    Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
    Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
    J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
    Liu Z; Ivanoff A; Klominek J
    Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma invasiveness responds variably to irradiation in a co-culture model.
    Nakamura JL; Haas-Kogan DA; Pieper RO
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):880-6. PubMed ID: 17889268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublethal dose of irradiation enhances invasion of malignant glioma cells through p53-MMP 2 pathway in U87MG mouse brain tumor model.
    Pei J; Park IH; Ryu HH; Li SY; Li CH; Lim SH; Wen M; Jang WY; Jung S
    Radiat Oncol; 2015 Aug; 10():164. PubMed ID: 26245666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
    Chen SH; Gillespie GY; Benveniste EN
    Glia; 2006 Jan; 53(2):191-200. PubMed ID: 16206166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
    Thorns V; Walter GF; Thorns C
    Anticancer Res; 2003; 23(5A):3937-44. PubMed ID: 14666700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells.
    Lettau I; Hattermann K; Held-Feindt J; Brauer R; Sedlacek R; Mentlein R
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):215-23. PubMed ID: 20142769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of MMP-9 gene expression by mangiferin in PMA-stimulated human astroglioma cells: involvement of PI3K/Akt and MAPK signaling pathways.
    Jung JS; Jung K; Kim DH; Kim HS
    Pharmacol Res; 2012 Jul; 66(1):95-103. PubMed ID: 22465218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
    Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
    J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential.
    Sreenath T; Matrisian LM; Stetler-Stevenson W; Gattoni-Celli S; Pozzatti RO
    Cancer Res; 1992 Sep; 52(18):4942-7. PubMed ID: 1325287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.